Literature DB >> 11359557

Guidelines for warfarin therapy following a thromboembolic event.

S K Sutton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11359557      PMCID: PMC1495209          DOI: 10.1111/j.1525-1497.2001.10219.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  5 in total

Review 1.  Antithrombotic therapy for venous thromboembolic disease.

Authors:  T M Hyers; R D Hull; J G Weg
Journal:  Chest       Date:  1989-02       Impact factor: 9.410

2.  A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

Authors:  C Kearon; M Gent; J Hirsh; J Weitz; M J Kovacs; D R Anderson; A G Turpie; D Green; J S Ginsberg; P Wells; B MacKinnon; J A Julian
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

3.  Adherence to guidelines for oral anticoagulation after venous thrombosis and pulmonary embolism.

Authors:  D A Ganz; R J Glynn; H Mogun; E L Knight; R L Bohn; J Avorn
Journal:  J Gen Intern Med       Date:  2000-11       Impact factor: 5.128

4.  Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism. Research Committee of the British Thoracic Society.

Authors: 
Journal:  Lancet       Date:  1992-10-10       Impact factor: 79.321

5.  Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis.

Authors:  M N Levine; J Hirsh; M Gent; A G Turpie; J Weitz; J Ginsberg; W Geerts; J LeClerc; J Neemeh; P Powers
Journal:  Thromb Haemost       Date:  1995-08       Impact factor: 5.249

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.